above 25C for more than 24 hours renders the vial unusable
What This Means Clinically For patients who have tried GLP-1 medications and experienced significant side effects, or who are not candidates for appetite-suppressing approaches, AOD 9604 represents a mechanistically different option
Patient Education Medication guidance: Provide detailed instructions on the injection method, dosage and possible side effects
May your follicles stay active, your dermal papilla cells stay protected, and your anagen phase stay extended.
Ideal candidates include: People with metabolic issues like insulin resistance or prediabetes Athletes or fitness enthusiasts seeking better energy and recovery Anyone interested in cellular health and longevity support MOTS-Cs role in mitochondrial function makes it a promising option for metabolic balance
AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol Lipolytic hGH fragment (AOD-9604) + GHRH analog (CJC-1295) + GH secretagogue (Ipamorelin) in one 12 mg blend research-only, not FDA-approved